EPO and chronic obstructive pulmonary disease: Many pathogenetic mechanisms underlie these associations, including systemic inflammation, the dysregulation of iron homeostasis, impaired bone marrow response to erythropoietin, shortened red cell lifespan, comorbidities in COPD, and nutritional disorders contributing to anemia such as renal disease [40].